1
Total investments
1
Early stage
0
Mid stage
0
Late stage
7y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Partner and Investor
Mar 2019
Neo Kuma Ventures invests in early stage psychedelic healthcare companies at the forefront of clinical research into illnesses including depression, PTSD, addiction, inflammation and chronic pain. By working with the leading companies in this field we will advance and redefine the standard of patient care.
Our fund invests in pre-seed to series A, where we can play a valuable role as investors.
For more information please email info@neokuma.co
Experience · 2 entries
All (2)
Investments (1)
2019
Partner and Investor
Mar 2019
Neo Kuma Ventures invests in early stage psychedelic healthcare companies at the forefront of clinical research into illnesses including depression, PTSD, addiction, inflammation and chronic pain. By working with the leading companies in this field we will advance and redefine the standard of patient care.
Our fund invests in pre-seed to series A, where we can play a valuable role as investors.
For more information please email info@neokuma.co
2011
Associate
Sep 2011
Slaughter and May is regarded as one of the most prestigious law firms in the world. We advise on high profile and groundbreaking international transactions and have an excellent and varied international client list.
We have a diverse and extensive international practice providing a full range of legal services. Mergers and Acquisitions, Corporate and Commercial and Financing represent our core practice areas. We also have leading practitioners in more specialist areas including Tax, Competition, Dispute Resolution, Commercial Real Estate, Pensions and Employment, Financial Regulation, Information Technology and Intellectual Property.
Our expertise covers the full spectrum of industry sectors to service a diverse range of clients from leading private equity boutiques to investment banks; start-up businesses to governments; retailers to entertainment companies; and diversified industrial conglomerates to premier league football clubs.